It has been reported that miR-93 activated the PI3K/AKT signaling pathway and promoted tumorigenesis and metastasis of NSCLC via targeting liver kinase B1 (LKB1) (15). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.